Evidence map›Paper›PMID 39597664›Full record

ArticleMicroorganisms2024

Effects of Prospective Audit and Feedback in Patients with Extended-Spectrum

Yota Yamada, Motoyasu Miyazaki, Hisako Kushima, Hitomi Hirata, Arata Ogawa, Yukie Komiya, Chika Hagiwara, Akio Nakashima, Hiroshi Ishii, Osamu Imakyure

Abstract read
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Pharmacist-driven antimicrobial stewardship: evolving roles in clinical practice.Journal of pharmaceutical health care and sciences · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yota YamadaDepartment of Pharmacy, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.ORCID 0009-0005-6297-6388
Motoyasu MiyazakiDepartment of Pharmacy, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.ORCID 0000-0002-4526-3045
Hisako KushimaDepartment of Infection Control and Prevention, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.
Hitomi HirataDepartment of Pharmacy, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.
Arata OgawaDepartment of Pharmacy, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.
Yukie KomiyaDepartment of Infection Control and Prevention, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.
Chika HagiwaraDepartment of Pharmacy, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.
Akio NakashimaDepartment of Pharmacy, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.ORCID 0009-0003-7953-2949
Hiroshi IshiiDepartment of Infection Control and Prevention, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.ORCID 0000-0002-2143-5922
Osamu ImakyureDepartment of Pharmacy, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial stewardship (AS) Guidelines by the Infectious Diseases Society of America recommend employing prospective audit and feedback (PAF) as an effective intervention in AS programs. Since July 2022, our hospital has implemented PAF for all patients with positive blood cultures, including those with extended-spectrum

Indexed as

antimicrobial stewardshipextended-spectrum β-lactamase-producing Escherichia coliprospective audit and feedbacktreatment failure rate

Identifiers

PMID39597664
PMCPMC11596308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.